CTNNB1 and hepatocellular carcinoma: Proof-of-concept studies for some pathways, such as CTNNB1 using proteolysis-targeted chimeras [49], the IGF pathway [50], TGFβ signaling in NASH-associated HCC [51], or oxidative stress [52], have shown some promise.